4
Changes in Ownership
Kairos Pharma, LTD. Filed Acc 0001493152-25-008105
CEO and Chairman acquired 14,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yu John S CEO and Chairman | 2025-01-01 | Grant or award | +14,000 | 5,355,838 | D |
Loading xslF345X05/ownership.xml…